A patient who had two recent molar extractions is now experiencing generalized malaise while on cephalexin 500 mg orally every 12 hours, with a slight rise in white‑blood‑cell count from 12.3 ×10⁹/L to 12.6 ×10⁹/L (high‑normal). Should I add an additional oral antibiotic or start intravenous antibiotics and repeat a CBC in three days?

Continue Current Oral Cephalexin Without Escalation

Your patient does not require additional antibiotics or IV therapy at this time. The clinical picture—generalized malaise with a minimal WBC rise from 12.3 to 12.6 ×10⁹/L in a patient who typically runs high-normal—does not meet criteria for severe infection requiring escalation 1.

---

Rationale for Continuing Current Therapy

Absence of Severe Infection Criteria

• The IDSA guidelines define severe skin and soft-tissue infections requiring IV therapy or escalation as those with systemic inflammatory response syndrome (SIRS): temperature >38°C or <36°C, tachypnea >24 breaths/min, tachycardia >90 bpm, or WBC >12,000 or <4,000 cells/µL 1.
• Your patient's WBC of 12.6 ×10⁹/L (12,600 cells/µL) barely exceeds the threshold and represents only a 0.3 ×10⁹/L increase from baseline—this is not a significant leukocytosis, especially in someone who runs high-normal 1.
• Generalized malaise alone, without fever, tachycardia, tachypnea, or progressive local signs (expanding erythema, purulence, abscess formation), does not warrant treatment escalation 1.

Cephalexin Is Appropriate First-Line Therapy

• Cephalexin 500 mg every 12 hours provides adequate coverage for the most common post-extraction pathogens: Staphylococcus aureus (methicillin-susceptible) and Streptococcus species 1, 2.
• The IDSA guidelines list cephalexin 500 mg four times daily as standard dosing for skin and soft-tissue infections, but twice-daily dosing (500 mg Q12h) has been shown effective in multiple studies and enhances compliance 2, 3.
• Cephalexin achieves high tissue concentrations and has cure rates of 90% or higher for streptococcal and staphylococcal infections 2.

---

When to Escalate Therapy

Add MRSA Coverage (Oral) If:

• The patient develops purulent drainage, abscess formation, or fails to improve after 48–72 hours on cephalexin 1.
• In such cases, add trimethoprim-sulfamethoxazole 1–2 double-strength tablets twice daily or doxycycline 100 mg twice daily to cover community-acquired MRSA 1.
• Cephalexin does not cover MRSA, so empiric MRSA coverage is indicated only if there is clinical failure or high local prevalence 1.

Switch to IV Antibiotics If:

• The patient develops SIRS criteria (fever, tachycardia, tachypnea, or WBC >12,000 with clinical deterioration) or hypotension 1.
• IV options include nafcillin or cefazolin for methicillin-susceptible S. aureus, or vancomycin if MRSA is suspected 1.
• IV therapy is also indicated if the patient cannot tolerate oral intake or has evidence of deep-space infection (e.g., Ludwig's angina, descending necrotizing mediastinitis) 1.

---

Monitoring Plan

Repeat CBC in 3 Days

• Your plan to recheck the CBC in 3 days is appropriate 4.
• Look for trending WBC: a rising count (e.g., >15,000 cells/µL) or development of bandemia suggests treatment failure and warrants escalation 5.
• A stable or declining WBC with clinical improvement (resolution of malaise, no fever, no local progression) confirms adequate therapy 5.

Clinical Red Flags Requiring Immediate Reassessment

• Fever (temperature >38°C), worsening pain or swelling, trismus (difficulty opening the mouth), dysphagia or dyspnea (suggesting deep-space spread), or purulent drainage 1.
• Any of these findings should prompt urgent re-evaluation, imaging (CT neck/chest if deep-space infection suspected), and likely escalation to IV antibiotics 1.

---

Common Pitfalls to Avoid

Do Not Reflexively Escalate Based on Mild WBC Elevation Alone

• A WBC of 12.6 ×10⁹/L in a patient who runs high-normal is not clinically significant, especially without other SIRS criteria 1, 5.
• Neutrophil percentage is a better predictor of bacteremia than absolute WBC count; if available, review the differential 5.

Do Not Add Antibiotics "Just in Case"

• Unnecessary antibiotic escalation increases the risk of Clostridioides difficile infection, drug resistance, and adverse effects (e.g., rash, diarrhea) 4.
• The FDA label for cephalexin explicitly warns that prolonged use may result in overgrowth of nonsusceptible organisms 4.

Ensure Adequate Duration of Therapy

• Post-extraction infections typically require 7–10 days of antibiotics 4.
• Patients often feel better early in the course but should complete the full regimen to prevent relapse and resistance 4.

---

Summary Algorithm

1. Continue cephalexin 500 mg Q12h for a total of 7–10 days 1, 2.
2. Recheck CBC in 3 days: if WBC stable or declining and patient improving clinically, no change needed 5.
3. Escalate to oral MRSA coverage (TMP-SMX or doxycycline) if no improvement by 48–72 hours or if purulent drainage develops 1.
4. Switch to IV antibiotics (cefazolin or vancomycin) if SIRS criteria, hypotension, or deep-space infection develops 1.
5. Reassess immediately if fever, trismus, dysphagia, dyspnea, or worsening local signs occur 1.